{
  "ticker": "LLY",
  "target_date": "2025-04-02",
  "actual_date": "2025-04-02",
  "collected_at": "2025-12-08T11:35:35.647828",
  "price": {
    "open": 790.51,
    "high": 815.18,
    "low": 790.51,
    "close": 813.5618896484375,
    "volume": 2683800,
    "change_1d_pct": 1.61,
    "change_7d_pct": -5.4,
    "change_30d_pct": -5.63
  },
  "technicals": {
    "rsi_14": 55.21,
    "sma_20": 829.01,
    "sma_50": 841.67,
    "macd": -9.636,
    "macd_signal": -6.443,
    "macd_histogram": -3.192,
    "bb_upper": 879.57,
    "bb_lower": 778.45,
    "price_vs_sma20_pct": -1.86,
    "price_vs_sma50_pct": -3.34,
    "volume_ratio": 0.78
  },
  "fundamentals": {
    "market_cap": 889809534976,
    "pe_ratio": 48.63229,
    "forward_pe": 43.8034,
    "price_to_book": 37.371426,
    "price_to_sales": 14.974967,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.74,
    "pct_from_52w_low": 59.12
  },
  "macro": {
    "spy": {
      "price": 561.3,
      "change_1d_pct": 0.63,
      "change_7d_pct": -1.9
    },
    "vix": {
      "level": 21.51,
      "signal": "ELEVATED"
    },
    "treasury_10y": {
      "yield_pct": 4.2
    },
    "dollar_index": {
      "level": 103.81
    },
    "gold": {
      "price": 3139.9
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Big Pharma Avoids Worst-Case Tariff Scenario",
      "source": "Yahoo",
      "datetime": 1743631415,
      "summary": "Drugmakers breathed a sigh of relief Wednesday after President Trump didn\u2019t announce pharmaceutical tariffs.  Plus, language in the executive order indicated medicines were exempted from the reciprocal tariffs that Trump did announce.  Drugmakers were combing over the executive order to clarify the ",
      "url": "https://finnhub.io/api/news?id=e56792421f40cd13cbd5b94e4465a2bf24427e7b41aded3c7608a2d37bd75b9a"
    },
    {
      "headline": "Hims Claws Back After Its Lilly-Rivaling Obesity Plan Faces An Unexpected Hitch",
      "source": "Yahoo",
      "datetime": 1743625975,
      "summary": "Hims stock clawed higher Wednesday though analysts laid out low expectations for Him & Hers' branded tirzepatide.",
      "url": "https://finnhub.io/api/news?id=7c0562153c3a0a24c8e0163dd5e00d1acff00381e6b683704e1d001b43392927"
    },
    {
      "headline": "Primary care firm knownwell joins LillyDirect to offer weight-management services",
      "source": "Yahoo",
      "datetime": 1743621707,
      "summary": "Primary care company knownwell said on Wednesday it will provide health and weight-management services on Eli Lilly's direct-to-consumer online healthcare platform, LillyDirect. Patients on LillyDirect will have access to physicians from knownwell for personalized services, knownwell said. The compa",
      "url": "https://finnhub.io/api/news?id=b85daa67b6fd5a153f9e1f783c36dc23494231170ebc2a46059dc492c3567e88"
    },
    {
      "headline": "Hims & Hers Zepbound Offering Won\u2019t Bring Needed Sales Boom, Analysts Say",
      "source": "Yahoo",
      "datetime": 1743617520,
      "summary": "Investors worry patients won\u2019t make that price leap and that Hims, which has built its business on affordable healthcare, will struggle to meet its revenue goal.",
      "url": "https://finnhub.io/api/news?id=dd36105d6190d2d1254e5d8f803f0ed0e88f7e1384aafb2a41f748400a0a8a3f"
    },
    {
      "headline": "Hims Dives After Its Lilly-Rivaling Obesity Plan Faces An Unexpected Hitch",
      "source": "Yahoo",
      "datetime": 1743609235,
      "summary": "Hims stock reversed lower Wednesday as analysts laid out low expectations for Him & Hers' branded tirzepatide.",
      "url": "https://finnhub.io/api/news?id=c6af30fc41669b4c2f928a17a02f2a221c6afd74fa91c6ef29716abd94d981f8"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-03-19",
      "description": "xslF345X05/wk-form4_1742416067.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000103/xslF345X05/wk-form4_1742416067.xml"
    },
    {
      "form": "4",
      "date": "2025-03-19",
      "description": "xslF345X05/wk-form4_1742415936.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000101/xslF345X05/wk-form4_1742415936.xml"
    },
    {
      "form": "4",
      "date": "2025-03-19",
      "description": "xslF345X05/wk-form4_1742415842.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000099/xslF345X05/wk-form4_1742415842.xml"
    },
    {
      "form": "4",
      "date": "2025-03-19",
      "description": "xslF345X05/wk-form4_1742415665.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000097/xslF345X05/wk-form4_1742415665.xml"
    },
    {
      "form": "4",
      "date": "2025-03-19",
      "description": "xslF345X05/wk-form4_1742415462.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000095/xslF345X05/wk-form4_1742415462.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}